Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALTH
DateTimeSourceHeadlineSymbolCompany
27/02/200821:54Edgar (US Regulatory)Allos Therapeutics Inc - Annual Report (10-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
27/02/200821:47Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
27/02/200812:38Edgar (US Regulatory)Allos Therapeutics Inc - Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
27/02/200812:30Business WireAllos Therapeutics Reports 2007 ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
21/02/200822:55Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
21/02/200822:52Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
21/02/200822:50Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
21/02/200822:48Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
21/02/200822:46Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
14/02/200820:52Edgar (US Regulatory)Allos Therapeutics Inc - Amended Statement of Ownership (SC 13G/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
14/02/200815:54Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Ownership (SC 13G)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
11/02/200813:00Business WireAllos Therapeutics to Report 2007 Results on February 27, 2008NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
06/02/200819:07Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Ownership (SC 13G)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
04/02/200820:23Edgar (US Regulatory)Allos Therapeutics Inc - Initial Statement of Beneficial Ownership (3)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
29/01/200813:00PR Newswire (US)Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
28/01/200813:00PR Newswire (US)Allos Therapeutics Appoints Bruce K. Bennett as Vice President, ManufacturingNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/01/200822:00Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/01/200821:59Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/01/200821:58Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/01/200821:57Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/01/200821:55Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/01/200821:47Edgar (US Regulatory)Allos Therapeutics Inc - Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/01/200813:00PR Newswire (US)Allos Therapeutics Initiates Phase 2b Study of PDX in Patients With Non-small Cell Lung CancerNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/01/200816:49Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/01/200816:40Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
02/01/200818:57Edgar (US Regulatory)Allos Therapeutics Inc - Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
27/12/200713:00PR Newswire (US)Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with PeriphNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
14/12/200721:05Edgar (US Regulatory)Allos Therapeutics Inc - Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
11/12/200713:00PR Newswire (US)Allos Therapeutics to Present at the 2008 JPMorgan Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/12/200713:00PR Newswire (US)Allos Therapeutics to Present at the 2007 RBC Capital Markets Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ALTH